Collagenase in the Treatment of Cellulite

Stony Brook University20 enrolled

Overview

The purpose of this study is to determine if collagenase injection will reduce or eliminate the appearance of cellulite of the thigh.

This is an open label study of collagenase injection therapy for reduction and/or elimination of cellulite of the posterolateral thighs.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Cellulite

Interventions

CollagenaseDRUG

One 0.58mg injection every two weeks for six weeks (total three 0.58mg injections)

BiologicalBIOLOGICAL

Collagenase injection

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 10 x 10 cm area of cellulite of the posterolateral thigh(s) Exclusion Criteria: * any chronic, serious or uncontrolled medical condition * inability to conform to study visits (12-15 per year)

Locations (1)

Dept. Orthopaedics, SUNY Stony Brook

Stony Brook, New York, United States

Outcomes

Primary Outcomes

Reduction and/or elimination of cellulite in the posterolateral thigh

Time frame: 6 months

Central Contacts

Marie A Badalamente, PhD

CONTACT

631 444 2215 Marie.Badalamente@stonybrookmedicine.edu

Gail Trocchio

CONTACT

631 444 2215 Gail.Trocchio@stonybrookmedicine.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.